http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5233024-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee602c630e57f59c6cfc1c1634e36064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c06d114257182ee7efd4c696c5fdb836
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-4233
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-42
filingDate 1991-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1993-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a36d8fbbb70ed324eb82b2675d6ab6f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_29a3b4298afb29f415015668d03ce258
publicationDate 1993-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5233024-A
titleOfInvention Anti-idiotypic monoclonal antibodies for mucoid pseudomonas aeruginosa, their preparation and use
abstract An anti-idiotypic monoclonal antibody, which induces production of mucoid exopolysaccharide-specific antibodies which are opsonic for mucoid Pseudemonas aeruginosa. The anti-idiotypic monoclonal antibody is produced by a cell line designated C9F5 and having ATCC accession No. HB10715. The anti-idiotypic monoclonal antibody is useful as a vaccine and for diagnostic purposes.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011059949-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006153856-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005155458-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003124631-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6962813-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7119172-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7230087-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5502039-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020178130-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005209219-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004087200-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004087200-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7812015-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016142660-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006062779-A1
priorityDate 1991-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4693891-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4677070-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4834975-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4970070-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4834976-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4965068-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4160023-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0101039-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4157389-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4578458-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4918163-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4918163-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4285936-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127455638
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2154
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10444661
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129322018

Total number of triples: 50.